Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

352 ARTÍCULOS , VIENDO DEL 301 AL 315

Roles of TREM2 in Alzheimer's disease

Qi X, Zhu K, Ke W, Wang J, Mao S, Chen G.

Transl Neurodegener. 2025 Oct 31;14(1):55. doi: 10.1186/s40035-025-00515-3.

Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study

Doecke JD, Bellomo G, Vermunt L, Alcolea D, Halbgebauer S, In 't Veld S, Mattsson-Carlgren N, Veverova K, Fowler CJ, Boonkamp L, Houtkamp IM, Koel-Simmerlink M, Verberk IMW, Gaetani L, Toja A, Wojdała AL, Fortea J, Pijnenburg Y, Lemstra A, van der Flier W, Hort J, Otto M, Hansson O, Parnetti L, Masters CL, Lleó A, González-Escalante A, Contador J, Suárez-Calvet M, Fernández-Lebrero A, Puig-Pijoan A, Ortiz-Romero P, Jiménez-Moyano E, Minguillón C, Del Campo M, Teunissen C.

Alzheimers Dement. 2025 Jun;21(6):e14573. doi: 10.1002/alz.14573.

Non-coding RNA biomarkers in Alzheimer's disease

Mohammadpour M, Saeidi K, Ferdosi F, Khanifar H, Dadgostar E, Zakizadeh F, Abdolghaderi S, Khatami SH.

Clin Chim Acta. 2025 Aug 15;576:120427. doi: 10.1016/j.cca.2025.120427. Epub 2025 Jun 14.

Spotlight on Alzheimer's disease and related dementias research in East Asia

Le W, Shen L, Guo T, Xie F.

Alzheimers Dement. 2025 Jul;21(7):e70479. doi: 10.1002/alz.70479.

Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease

Montoliu-Gaya L, Bian S, Dammer EB, Alcolea D, Sauer M, Martá-Ariza M, Ashton NJ, Belbin O, Fuchs J, Watson CM, Ping L, Duong DM, Nilsson J, Barroeta I, Lantero-Rodriguez J, Videla L, Benejam B, Roberts BR, Blennow K, Seyfried NT, Levey AI, Carmona-Iragui M, Gobom J, Lleó A, Wisniewski T, Zetterberg H, Fortea J, Johnson ECB.

Nat Commun. 2025 Jul 1;16(1):6003. doi: 10.1038/s41467-025-61054-z.

Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer's disease in a multicenter and multiethnic aging population

Lan G, Wang M, Gonzalez-Ortiz F, Zhang L, Li A, Li B, Jiang M, Yang J, Chen X, Shi D, Fan X, Cai Y, Sun P, Liu L, Li J, He Z, Fang L, Zhou X, Chen L, Wang Y, Li M, Liu Z, Wang Q, Xu L, Zhou L, Cheng G, Wang X, Ran P, Wang L, Sun K, Han Y, Guan Y, Blennow K, Xie F, Guo T.

Nat Aging. 2025 Aug;5(8):1601-1618. doi: 10.1038/s43587-025-00904-3. Epub 2025 Jun 23.

Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study

Zúñiga CH, Acosta BI, Menchaca R, Amescua CA, Hong S, Hui L, Gil M, Rhee YH, Yoon S, Kim M, Chang PY, Kim YM, Song PY, Betito K.

Alzheimers Res Ther. 2025 Feb 12;17(1):40. doi: 10.1186/s13195-025-01681-2.

The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology

McDade EM, Barthélemy NR, Wang G, Li Y, Cao Y, Gordon B, Benzinger TLS, Clifford D, Goate AM, Renton AE, Hassenstab J, Llibre-Guerra JJ, Perrin RJ, Xiong C, Cruchaga C, Mummery CJ, Berman SB, Lah J, Roberson ED, Van Dyck C, Gauthier S, Masters CL, Masellis M, Bittner T, Yaari R, Chhatwal J, Chrem P, Brooks W, Suzuki K, Levin JJ, Jucker M, Ringman J, Wallon D, Ikeuchi T, Lee JH, Roh JH, Schofield P, Fox NC, Ryan NS, Vöglein J, Karch C, Ibáñez L, Day GS, Sánchez-Valle R, Daniels A, Morris JC, Supnet-Bell C, Levey AI, Bateman RJ; DIAN‐TU Study Team and DIAN Obs Team.

Alzheimers Dement. 2025 Sep;21(9):e70689. doi: 10.1002/alz.70689.

Lecanemab treatment for Alzheimer's Disease of varying severities and associated plasma biomarkers monitoring: A multi-center real-world study in China

Chen S, Ou R, Wei Q, Li C, Song W, Zhao B, Yang J, Fu J, Ma Y, Liu J, Wang X, Fang D, Hu T, Xiao L, Zhang S, Huang R, Guo X, Feng F, Chen X, Shang H.

Alzheimers Dement. 2025 Oct;21(10):e70750. doi: 10.1002/alz.70750.

Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease

Liu X, Baxley S, Hebron M, Turner RS, Moussa C.

Int J Mol Sci. 2025 May 23;26(11):5044. doi: 10.3390/ijms26115044.

Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium

Verberk IMW, Gouda M, Antwi-Berko D, van Leeuwenstijn M, Bongers B, Houtkamp IM, van der Flier WM, Janelidze S, Hansson O, Bastard NL, Vandijck M, Hunter J, Honigberg L, Kirmess KM, Verghese PB, Blennow K, Zetterberg H, Meyers EA, Edelmayer RM, Teunissen C.

Alzheimers Dement. 2025 Oct;21(10):e70752. doi: 10.1002/alz.70752.

A head-to-head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic

Anastasi F, Fernández-Lebrero A, Ashton NJ, Ortiz-Romero P, Torres-Torronteras J, González-Escalante A, Milà-Alomà M, Contador J, García-Escobar G, Manero-Borràs RM, Navalpotro-Gómez I, Jiménez-Moyano E, Sahajan A, Hao Q, Zhang B, Jeromin A, Le Bastard N, Nadal A, Mousavi T, Kollmorgen G, Carboni M, Grau-Rivera O, Zetterberg H, Del Campo M, Blennow K, Puig-Pijoan A, Suárez-Calvet M.

Alzheimers Dement. 2025 Feb;21(2):e14609. doi: 10.1002/alz.14609.

A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests

Warmenhoven N, Salvadó G, Janelidze S, Mattsson-Carlgren N, Bali D, Orduña Dolado A, Kolb H, Triana-Baltzer G, Barthélemy NR, Schindler SE, Aschenbrenner AJ, Raji CA, Benzinger TLS, Morris JC, Ibanez L, Timsina J, Cruchaga C, Bateman RJ, Ashton N, Arslan B, Zetterberg H, Blennow K, Pichet Binette A, Hansson O.

Brain. 2025 Feb 3;148(2):416-431. doi: 10.1093/brain/awae346.

C-reactive protein-mediated dementia

Tang JM, Lu Q, Lin HX, Li JQ, Zhu XC, Ma T.

Psychogeriatrics. 2025 May;25(3):e70032. doi: 10.1111/psyg.70032.

An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease

Arnsten AFT, Del Tredici K, Barthélemy NR, Gabitto M, van Dyck CH, Lein E, Braak H, Datta D.

Alzheimers Dement. 2025 Aug;21(8):e70404. doi: 10.1002/alz.70404.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias